232 related articles for article (PubMed ID: 12547017)
1. Selective retinoids and rexinoids in cancer therapy and chemoprevention.
Zusi FC; Lorenzi MV; Vivat-Hannah V
Drug Discov Today; 2002 Dec; 7(23):1165-74. PubMed ID: 12547017
[TBL] [Abstract][Full Text] [Related]
2. Retinoids and rexinoids in cancer prevention: from laboratory to clinic.
Uray IP; Dmitrovsky E; Brown PH
Semin Oncol; 2016 Feb; 43(1):49-64. PubMed ID: 26970124
[TBL] [Abstract][Full Text] [Related]
3. Renaissance of the biologically active vitamin A derivatives: established and novel directed therapies for cancer and chemoprevention.
Brtko J; Thalhamer J
Curr Pharm Des; 2003; 9(25):2067-77. PubMed ID: 14529416
[TBL] [Abstract][Full Text] [Related]
4. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
[TBL] [Abstract][Full Text] [Related]
5. Retinoids as chemopreventive agents.
Ralhan R; Kaur J
J Biol Regul Homeost Agents; 2003; 17(1):66-91. PubMed ID: 12757022
[TBL] [Abstract][Full Text] [Related]
6. Synthetic retinoids and their nuclear receptors.
Dawson MI
Curr Med Chem Anticancer Agents; 2004 May; 4(3):199-230. PubMed ID: 15134501
[TBL] [Abstract][Full Text] [Related]
7. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
[TBL] [Abstract][Full Text] [Related]
8. Retinoids in cancer therapy and chemoprevention: promise meets resistance.
Freemantle SJ; Spinella MJ; Dmitrovsky E
Oncogene; 2003 Oct; 22(47):7305-15. PubMed ID: 14576840
[TBL] [Abstract][Full Text] [Related]
9. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
12. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
[TBL] [Abstract][Full Text] [Related]
13. Retinoids and TRAIL: two cooperating actors to fight against cancer.
Altucci L; Gronemeyer H
Vitam Horm; 2004; 67():319-45. PubMed ID: 15110184
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic advances in cutaneous T-cell lymphoma (CTCL): from retinoids to rexinoids.
Stadler R; Kremer A
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S7-10. PubMed ID: 16516669
[TBL] [Abstract][Full Text] [Related]
15. Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy.
Dobrotkova V; Chlapek P; Mazanek P; Sterba J; Veselska R
BMC Cancer; 2018 Nov; 18(1):1059. PubMed ID: 30384831
[TBL] [Abstract][Full Text] [Related]
16. Retinoids in chemoprevention of cancer.
Verma AK
J Biol Regul Homeost Agents; 2003; 17(1):92-7. PubMed ID: 12757023
[TBL] [Abstract][Full Text] [Related]
17. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in receptor-selective retinoids.
Nagpal S; Chandraratna RA
Curr Pharm Des; 2000 Jun; 6(9):919-31. PubMed ID: 10828316
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer.
Niles RM
Nutrition; 2000; 16(11-12):1084-9. PubMed ID: 11118831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]